UB Paderborn / Katalog / Suche / in CDI

Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency

The European respiratory journal, 2009-06, Vol.33 (6), p.1345-1353

2009

Link zum Volltext

Verfügbarkeit prüfen

The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening

International journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.43-52

2022

Link zum Volltext

Verfügbarkeit prüfen

Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.1075-1083

2019

Link zum Volltext

Verfügbarkeit prüfen

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.1245-1252

2020

Link zum Volltext

Verfügbarkeit prüfen

Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.927-933

2016

Link zum Volltext

Verfügbarkeit prüfen

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.3477-3485

2021

Link zum Volltext

Verfügbarkeit prüfen

Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.3689-3698

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)

Thorax, 2008-12, Vol.63 (12), p.1091-1095

2008

Link zum Volltext

Verfügbarkeit prüfen

Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema: proof of concept for a novel diagnostic technique

Clinical physiology and functional imaging, 2018-11, Vol.38 (6), p.1008-1014

2018

Link zum Volltext

Verfügbarkeit prüfen

The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency

Scandinavian journal of gastroenterology, 2009, Vol.44 (11), p.1349-1355

2009

Link zum Volltext

Verfügbarkeit prüfen

The liver in 30-year-old individuals with alpha1-antitrypsin deficiency

Scandinavian journal of gastroenterology, 2009-11, Vol.44 (11), p.1349-1355

2009

Link zum Volltext

Verfügbarkeit prüfen

Decline in FEV1 related to smoking status in individuals with severe α1-antitrypsin deficiency (PiZZ)

The European respiratory journal, 1999, Vol.13 (2), p.247-251

1999

Link zum Volltext

Verfügbarkeit prüfen

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development

The European respiratory journal, 2007-03, Vol.29 (3), p.582-586

2007

Link zum Volltext

Verfügbarkeit prüfen

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha(1)-antitrypsin deficiency

The European respiratory journal, 2009-06, Vol.33 (6), p.1345

2009

Link zum Volltext

Verfügbarkeit prüfen

The forced oscillation technique is a sensitive method for detecting obstructive airway disease in patients with primary Sjögren's syndrome

Scandinavian journal of rheumatology, 2014-01, Vol.43 (4), p.324-328

2014

Link zum Volltext

Verfügbarkeit prüfen

Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age

Medicine (Baltimore), 2017-03, Vol.96 (12), p.e6180

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.525-530

2019

Link zum Volltext

Verfügbarkeit prüfen

Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.495-500

2017

Link zum Volltext

Verfügbarkeit prüfen

C80-B MULTI-MODALITY ASSESSMENT OF COPD, ASTHMA, AND ASTHMA-COPD OVERLAP SYNDROME: Ccomparison Of The Forced Oscillation Technique And Spirometry In COPD And Alpha-1-Antitrypsin Deficient Patients

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

Exploring the role of CT densitometry: a randomised study of augmentation therapy in {alpha}1-antitrypsin deficiency

The European respiratory journal, 2009-06, Vol.33 (6), p.1345-1353

2009

Link zum Volltext

Verfügbarkeit prüfen

Environmental correlates of impaired lung function in non-smokers with severe α1-antitrypsin deficiency (PiZZ)

Thorax, 1998-11, Vol.53 (11), p.939-943

1998

Link zum Volltext

Verfügbarkeit prüfen

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.1663-1669

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome

Journal of rheumatology, 2015-03, Vol.42 (3), p.464

2015

Link zum Volltext

Verfügbarkeit prüfen

Frequent development of chronic obstructive pulmonary disease in primary SS―results of a longitudinal follow-up

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.941-946

2012

Link zum Volltext

Verfügbarkeit prüfen

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden

International journal of chronic obstructive pulmonary disease, 2016-07, Vol.2016 (Issue 1), p.1663-1669

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency

The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening

Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population

Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42

Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency

Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)

Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema: proof of concept for a novel diagnostic technique

The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency

The liver in 30-year-old individuals with alpha1-antitrypsin deficiency

Decline in FEV1 related to smoking status in individuals with severe α1-antitrypsin deficiency (PiZZ)

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha(1)-antitrypsin deficiency

The forced oscillation technique is a sensitive method for detecting obstructive airway disease in patients with primary Sjögren's syndrome

Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age

Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years

Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years

C80-B MULTI-MODALITY ASSESSMENT OF COPD, ASTHMA, AND ASTHMA-COPD OVERLAP SYNDROME: Ccomparison Of The Forced Oscillation Technique And Spirometry In COPD And Alpha-1-Antitrypsin Deficient Patients

Exploring the role of CT densitometry: a randomised study of augmentation therapy in {alpha}1-antitrypsin deficiency

Environmental correlates of impaired lung function in non-smokers with severe α1-antitrypsin deficiency (PiZZ)

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden

Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome

Frequent development of chronic obstructive pulmonary disease in primary SS―results of a longitudinal follow-up

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden

Suchergebnisse filtern